Peter P. Luk

668 total citations
32 papers, 471 citations indexed

About

Peter P. Luk is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter P. Luk has authored 32 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter P. Luk's work include Salivary Gland Tumors Diagnosis and Treatment (13 papers), Ear and Head Tumors (12 papers) and Tumors and Oncological Cases (7 papers). Peter P. Luk is often cited by papers focused on Salivary Gland Tumors Diagnosis and Treatment (13 papers), Ear and Head Tumors (12 papers) and Tumors and Oncological Cases (7 papers). Peter P. Luk collaborates with scholars based in Australia, Switzerland and Italy. Peter P. Luk's co-authors include Ruta Gupta, Christina Selinger, Jonathan R. Clark, Bing Yu, Sandra O’Toole, Timothy J. Eviston, Trina Lum, Michael Boyer, Kan Gao and Wendy A. Cooper and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncotarget.

In The Last Decade

Peter P. Luk

31 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter P. Luk Australia 12 282 279 109 106 98 32 471
Alyssa Luvison United States 8 170 0.6× 211 0.8× 76 0.7× 104 1.0× 84 0.9× 9 430
Aoi Sukeda Japan 10 223 0.8× 203 0.7× 51 0.5× 114 1.1× 51 0.5× 19 535
Aditya Shreenivas United States 9 220 0.8× 194 0.7× 33 0.3× 41 0.4× 67 0.7× 47 340
Samhita Chakraborty United States 8 235 0.8× 177 0.6× 68 0.6× 33 0.3× 119 1.2× 18 330
Rafke Schoffelen Netherlands 10 209 0.7× 136 0.5× 20 0.2× 58 0.5× 76 0.8× 12 430
Raffaele Farabi Italy 8 184 0.7× 138 0.5× 36 0.3× 145 1.4× 63 0.6× 12 432
Kunio Araki Japan 15 215 0.8× 101 0.4× 30 0.3× 227 2.1× 47 0.5× 36 599
Joaquin Garcia United States 6 280 1.0× 231 0.8× 32 0.3× 53 0.5× 28 0.3× 9 450
Silvia Damian Italy 10 272 1.0× 149 0.5× 17 0.2× 143 1.3× 50 0.5× 36 443
Jin Haeng Chung South Korea 13 153 0.5× 123 0.4× 24 0.2× 148 1.4× 77 0.8× 36 435

Countries citing papers authored by Peter P. Luk

Since Specialization
Citations

This map shows the geographic impact of Peter P. Luk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter P. Luk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter P. Luk more than expected).

Fields of papers citing papers by Peter P. Luk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter P. Luk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter P. Luk. The network helps show where Peter P. Luk may publish in the future.

Co-authorship network of co-authors of Peter P. Luk

This figure shows the co-authorship network connecting the top 25 collaborators of Peter P. Luk. A scholar is included among the top collaborators of Peter P. Luk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter P. Luk. Peter P. Luk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheung, Veronica, Peter P. Luk, Tsu‐Hui Low, et al.. (2023). Prognostic and predictive biomarkers in head and neck cancer: something old, something new, something borrowed, something blue and a sixpence in your shoe. Pathology. 56(2). 170–185. 3 indexed citations
2.
Cheung, Veronica, Cheok Soon Lee, Kevin Nguyen, et al.. (2023). MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinoma. Pathology. 55(4). 456–465. 3 indexed citations
3.
Vargas, Ana Cristina, Fiona Bonar, Daniel Wong, et al.. (2021). NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population. Pathology. 53(6). 705–712. 5 indexed citations
4.
Luk, Peter P., et al.. (2020). Catheter entrapment in the Chiari network during catheter ablation. HeartRhythm Case Reports. 6(12). 896–898. 3 indexed citations
5.
Mueller, Simon A., Marie Gauthier, James Blackburn, et al.. (2020). Molecular patterns in salivary duct carcinoma identify prognostic subgroups. Modern Pathology. 33(10). 1896–1909. 21 indexed citations
6.
Ebrahimi, Ardalan, Ruta Gupta, Peter P. Luk, et al.. (2020). Number of nodal metastases and the American Joint Committee on cancer staging of head and neck cutaneous squamous cell carcinoma: A multicenter study. Oral Oncology. 111. 104855–104855. 11 indexed citations
7.
Lomax, Anna J., Martin Tattersall, David M. Thomas, et al.. (2020). PD‐1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma. Cancer Reports. 4(2). e1327–e1327. 7 indexed citations
8.
9.
Mazzola, Francesco, Ruta Gupta, Peter P. Luk, et al.. (2019). The Milan System for Reporting Salivary Gland Cytopathology—Proposed modifications to improve clinical utility. Head & Neck. 41(8). 2566–2573. 16 indexed citations
10.
Ebrahimi, Ardalan, Peter P. Luk, Tsu‐Hui Low, et al.. (2019). Positive survival trend in metastatic head and neck cutaneous squamous cell carcinoma over four‐decades: Multicenter study. Head & Neck. 41(11). 3826–3832. 6 indexed citations
11.
Luk, Peter P., et al.. (2019). Mammary-type myofibroblastoma in the head and neck region. Pathology. 51(5). 544–547.
12.
Luk, Peter P., Christina Selinger, Annabelle Mahar, & Wendy A. Cooper. (2018). Biomarkers for ALK and ROS1 in Lung Cancer: Immunohistochemistry and Fluorescent In Situ Hybridization. Archives of Pathology & Laboratory Medicine. 142(8). 922–928. 19 indexed citations
13.
Luk, Peter P., Christina Selinger, Wendy A. Cooper, et al.. (2018). Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms. Head and Neck Pathology. 13(3). 397–414. 4 indexed citations
14.
Luk, Peter P., James Wykes, Christina Selinger, et al.. (2016). Diagnostic and prognostic utility of Mastermind-like 2 (MAML2) gene rearrangement detection by fluorescent in situ hybridization (FISH) in mucoepidermoid carcinoma of the salivary glands. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 121(5). 530–541. 48 indexed citations
15.
Luk, Peter P., et al.. (2015). Punch biopsy of melanoma causing tumour cell implantation: Another peril of utilising partial biopsies for melanocytic tumours. Australasian Journal of Dermatology. 56(3). 227–231. 1 indexed citations
16.
Luk, Peter P., Christina Selinger, Timothy J. Eviston, et al.. (2015). Mammary analogue secretory carcinoma: an evaluation of its clinicopathological and genetic characteristics. Pathology. 47(7). 659–666. 37 indexed citations
17.
Shen, Han, S. Decollogne, Pierre J. Dilda, et al.. (2015). Dual-targeting of aberrant glucose metabolism in glioblastoma. Journal of Experimental & Clinical Cancer Research. 34(1). 14–14. 43 indexed citations
18.
Decollogne, S., Swapna Joshi, Sylvia A. Chung, et al.. (2015). Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells. Gynecologic Oncology. 138(2). 363–371. 16 indexed citations
19.
Luk, Peter P., Bing Yu, Christina Selinger, et al.. (2015). Salivary duct carcinoma: clinicopathologic features, morphologic spectrum and somatic mutations. 11. 54 indexed citations
20.
Luk, Peter P., Peter Galettis, & Matthew Links. (2011). ERK phosphorylation predicts synergism between gemcitabine and the epidermal growth factor receptor inhibitor AG1478. Lung Cancer. 73(3). 274–282. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alyssa Luvison Breakdown of academic impact, for papers by Aoi Sukeda Breakdown of academic impact, for papers by Aditya Shreenivas Breakdown of academic impact, for papers by Samhita Chakraborty Breakdown of academic impact, for papers by Rafke Schoffelen Breakdown of academic impact, for papers by Raffaele Farabi Breakdown of academic impact, for papers by Kunio Araki Breakdown of academic impact, for papers by Joaquin Garcia Breakdown of academic impact, for papers by Silvia Damian Breakdown of academic impact, for papers by Jin Haeng Chung
Rankless by CCL
2026